Screener
ImmunityBio, Inc. IBRX Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from ImmunityBio, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 7:37 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001326110-26-000059
FAQ
- What is ImmunityBio, Inc.'s current ratio?
- ImmunityBio, Inc. (IBRX) reported current ratio of 6.7× in Q1 2026.
- How has ImmunityBio, Inc.'s current ratio changed year-over-year?
- ImmunityBio, Inc.'s current ratio increased by 200.5% year-over-year, from 2.2× to 6.7×.
- What is the long-term trend for ImmunityBio, Inc.'s current ratio?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s current ratio has grown at a 25.5% compound annual growth rate (CAGR), from 1.6× to 5.1×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about ImmunityBio, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude